ES2196332T3 - Derivados de hexahidro-pirido(4,3-b)indol como farmacos antipsicoticos. - Google Patents
Derivados de hexahidro-pirido(4,3-b)indol como farmacos antipsicoticos.Info
- Publication number
- ES2196332T3 ES2196332T3 ES97924014T ES97924014T ES2196332T3 ES 2196332 T3 ES2196332 T3 ES 2196332T3 ES 97924014 T ES97924014 T ES 97924014T ES 97924014 T ES97924014 T ES 97924014T ES 2196332 T3 ES2196332 T3 ES 2196332T3
- Authority
- ES
- Spain
- Prior art keywords
- 6alkyl
- hydrogen
- pct
- formula
- date nov
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title abstract 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- -1 mercapto, amino Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
LA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA (I), A LAS SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES Y A LAS FORMAS ESTEREOQUIMICAMENTE ISOMERAS DE LOS MISMOS, DONDE ALK ES ALCANODIILO C1-6 ; R1 ES HIDROGENO, ALQUILO C1-6 , RILO O ARILALQUILO C1-6 ; R2 , R3 Y R4 SE SELECCIONAN CADA UNO INDEPENDIENTEMENTE A PARTIR DE HIDROGENO, HALO, HIDROXILO, NITRO, CIANO, ALQUILO C1-6 , ALQUILOXI C1-6 , TRIFLUOROMETILO, ALQUILTIO C1-6 , MERCAPTO, AMINO, MONO - Y DI(ALQUIL C1-6)AMINO, CARBXILO, AL QUILOXICARBONILO C1-6 O ALQUILCARBONILO C1-6 ; R5 ES HIDROGENO, ALQUILO C1-6 , ALQUILOXI C1-6 , A LQUILTIO C1-6 , O UN RADICAL DE FORMULA - NR8 R9 , DONDE R8 Y R9 SE SELECCIONAN CADA UNO INDEPEND IENTEMENTE A PARTIR DE HIROGENO, ALQUILO C 1-6 , FENILO O FENILALQUILO C1-6 ; R7 ES HIDROGENO O ALQUILO C1-6 ; O R6 Y R7 CONJUNTAMENTE PUEDEN FORMAR UN RA DICAL BIVALENTE DE FORMULA - R6-R7 -. DICHOS COMPUESTOS TIENEN ACTIVIDAD ANTAGONISTA CENTRAL DE DOPAMINA Y SEROTONINA. SE DESCRIBE ASIMISMO LA PREPARACION DE DICHOS COMPUESTOS, COMPOSICIONES QUE LOS CONTIENEN Y SU UTILIZACION COMO MEDICINA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96201450 | 1996-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2196332T3 true ES2196332T3 (es) | 2003-12-16 |
Family
ID=8224021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97924014T Expired - Lifetime ES2196332T3 (es) | 1996-05-23 | 1997-05-15 | Derivados de hexahidro-pirido(4,3-b)indol como farmacos antipsicoticos. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6057325A (es) |
| EP (1) | EP0902684B1 (es) |
| JP (1) | JP2000510860A (es) |
| CN (1) | CN1149996C (es) |
| AT (1) | ATE236636T1 (es) |
| AU (1) | AU714113B2 (es) |
| CA (1) | CA2254755C (es) |
| CY (1) | CY2381B1 (es) |
| CZ (1) | CZ287961B6 (es) |
| DE (1) | DE69720715T2 (es) |
| DK (1) | DK0902684T3 (es) |
| ES (1) | ES2196332T3 (es) |
| IL (1) | IL127177A (es) |
| MY (1) | MY125562A (es) |
| NO (1) | NO311724B1 (es) |
| NZ (1) | NZ332310A (es) |
| PL (1) | PL187345B1 (es) |
| PT (1) | PT902684E (es) |
| SI (1) | SI0902684T1 (es) |
| TW (1) | TW470745B (es) |
| WO (1) | WO1997044040A1 (es) |
| ZA (1) | ZA974470B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1136493A1 (en) * | 2000-03-23 | 2001-09-26 | Sanofi-Synthelabo | 2-(Thienopyridinyl)pyrimidone, 2-(furopyridinyl)pyrimidone 2-(isoquinolinyl)pyrimidone, 2-(pyridoindolyl)pyrimidone and 2-(benzofuropyridinyl)pyrimidone derivatives |
| WO2003014118A1 (en) * | 2001-08-08 | 2003-02-20 | Pharmacia & Upjohn Company | THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES |
| ES2364046T3 (es) * | 2002-12-19 | 2011-08-23 | Bristol-Myers Squibb Company | Gamma-carbolinas tricíclicas sustituidas utilizadas como agonistas y antagonistas de los receptores de la serotonina. |
| DE602004019118D1 (de) * | 2003-09-17 | 2009-03-05 | Janssen Pharmaceutica Nv | Kondensierte heterocyclische verbindungen als modulatoren des serotoninrezeptors |
| EP1944306A1 (en) * | 2003-09-17 | 2008-07-16 | Janssen Pharmaceutica, N.V. | Fused heterocyclic compounds as serotonin receptor modulators |
| CN1882590B (zh) * | 2003-09-17 | 2014-03-05 | 詹森药业有限公司 | 作为血清素受体调节剂的稠合杂环化合物 |
| KR101168611B1 (ko) | 2003-09-17 | 2012-08-03 | 얀센 파마슈티카 엔.브이. | 세로토닌 수용체 조절자로서의 융합된 헤테로사이클릭 화합물 |
| RU2338537C2 (ru) * | 2006-01-25 | 2008-11-20 | Сергей Олегович Бачурин | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| CA2719824A1 (en) * | 2007-08-01 | 2009-02-05 | Medivation Neurology, Inc. | Methods and compositions for treating schizophrenia using antipsychotic combination therapy |
| US8907097B2 (en) | 2008-10-31 | 2014-12-09 | Medivation Technologies, Inc. | Pyrido[4,3-b]indoles containing rigid moieties |
| AU2009308708B2 (en) | 2008-10-31 | 2015-11-19 | Medivation Technologies, Inc. | Azepino [4, 5-b] indoles and methods of use |
| BR112013021126A2 (pt) | 2011-02-18 | 2019-09-24 | Medivation Technologies Inc | método para reduzir a pressão sanguínea, método para aumentar o fluxo sanguíneo renal ou diminuir a reabsorção de sódio, método para tratar uma doença, kit, composto e composição farmacêutica |
| US20150315188A1 (en) * | 2012-08-22 | 2015-11-05 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
| CN120607526B (zh) * | 2024-05-31 | 2026-04-03 | 和径医药科技（上海）有限公司 | 三并环类化合物、其药物组合物及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR205452A1 (es) * | 1973-12-06 | 1976-05-07 | Endo Lab | Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles |
| US4337250A (en) * | 1979-07-30 | 1982-06-29 | Pfizer Inc. | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents |
-
1997
- 1997-05-01 TW TW086105765A patent/TW470745B/zh not_active IP Right Cessation
- 1997-05-15 WO PCT/EP1997/002710 patent/WO1997044040A1/en not_active Ceased
- 1997-05-15 PL PL97330079A patent/PL187345B1/pl not_active IP Right Cessation
- 1997-05-15 JP JP09541588A patent/JP2000510860A/ja not_active Ceased
- 1997-05-15 NZ NZ332310A patent/NZ332310A/xx unknown
- 1997-05-15 CZ CZ19983774A patent/CZ287961B6/cs not_active IP Right Cessation
- 1997-05-15 SI SI9730542T patent/SI0902684T1/xx unknown
- 1997-05-15 IL IL12717797A patent/IL127177A/xx not_active IP Right Cessation
- 1997-05-15 PT PT97924014T patent/PT902684E/pt unknown
- 1997-05-15 DE DE69720715T patent/DE69720715T2/de not_active Expired - Fee Related
- 1997-05-15 CN CNB971948739A patent/CN1149996C/zh not_active Expired - Fee Related
- 1997-05-15 AT AT97924014T patent/ATE236636T1/de not_active IP Right Cessation
- 1997-05-15 DK DK97924014T patent/DK0902684T3/da active
- 1997-05-15 ES ES97924014T patent/ES2196332T3/es not_active Expired - Lifetime
- 1997-05-15 AU AU29616/97A patent/AU714113B2/en not_active Ceased
- 1997-05-15 CA CA002254755A patent/CA2254755C/en not_active Expired - Fee Related
- 1997-05-15 EP EP97924014A patent/EP0902684B1/en not_active Expired - Lifetime
- 1997-05-15 US US09/180,366 patent/US6057325A/en not_active Expired - Fee Related
- 1997-05-22 MY MYPI97002245A patent/MY125562A/en unknown
- 1997-05-22 ZA ZA974470A patent/ZA974470B/xx unknown
-
1998
- 1998-11-19 NO NO19985389A patent/NO311724B1/no unknown
-
2003
- 2003-11-04 CY CY0300075A patent/CY2381B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO985389D0 (no) | 1998-11-19 |
| PT902684E (pt) | 2003-08-29 |
| ATE236636T1 (de) | 2003-04-15 |
| DE69720715D1 (en) | 2003-05-15 |
| MY125562A (en) | 2006-08-30 |
| WO1997044040A1 (en) | 1997-11-27 |
| PL187345B1 (pl) | 2004-06-30 |
| IL127177A0 (en) | 1999-09-22 |
| CN1219875A (zh) | 1999-06-16 |
| NZ332310A (en) | 1999-08-30 |
| US6057325A (en) | 2000-05-02 |
| CN1149996C (zh) | 2004-05-19 |
| CY2381B1 (en) | 2004-06-04 |
| AU2961697A (en) | 1997-12-09 |
| CA2254755A1 (en) | 1997-11-27 |
| AU714113B2 (en) | 1999-12-16 |
| IL127177A (en) | 2003-10-31 |
| EP0902684A1 (en) | 1999-03-24 |
| EP0902684B1 (en) | 2003-04-09 |
| TW470745B (en) | 2002-01-01 |
| CA2254755C (en) | 2007-01-16 |
| ZA974470B (en) | 1998-11-23 |
| CZ287961B6 (cs) | 2001-03-14 |
| JP2000510860A (ja) | 2000-08-22 |
| SI0902684T1 (en) | 2003-10-31 |
| DK0902684T3 (da) | 2004-03-29 |
| PL330079A1 (en) | 1999-04-26 |
| NO985389L (no) | 1999-01-20 |
| CZ377498A3 (cs) | 1999-02-17 |
| DE69720715T2 (de) | 2004-03-11 |
| NO311724B1 (no) | 2002-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| AP1468A (en) | Hiv inhibiting pyrimidine derivatives. | |
| BG104716A (en) | Trisubstituted 1,3,5-triazine derivatives for the treatment of hiv infection | |
| AR030959A1 (es) | Derivados de aminoalcoholes, procedimiento para prepararlos, el uso de los mismos para preparar medicamentos y las composiciones farmaceuticas que las contienen | |
| UY25679A1 (es) | Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer | |
| HUP0201472A2 (hu) | HIV-integráz ellen gátló hatású heteroaromás származékok | |
| DK0871606T3 (da) | Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet | |
| PT902684E (pt) | Derivados hexa-hidro-pirido(4,3-b)indolo utilizados como farmacos antipsicoticos | |
| NO980919L (no) | 8-azabicyklo(3.2.1)okt-2-ene derivater, og deres anvendelse til fremstilling av et legemiddel | |
| TR200103460T2 (tr) | 5-Fenil-pirimidin türevleri | |
| FR2712591B1 (fr) | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. | |
| IL134894A (en) | 2-substituted-1,3,4,5-tetrahydro-2h-gamma-carbolines, their preparation and pharmaceutical compositions containing them | |
| MY130950A (en) | 4-(1h-indol-1-yl)-1-piperidinyl derivatives | |
| ES2175405T3 (es) | Derivados de adenosina. | |
| DE69838385D1 (de) | Angiogenese-hemmende 5-substituierte-1,2,4-thiadiazolylderivate | |
| NZ505060A (en) | 2-Aryl or heterocyclyl substituted indole derivatives useful for the treatment of osteoporosis | |
| DE69813886D1 (de) | Naphthalin derivate | |
| NO973242L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti | |
| BG105521A (en) | Benzisoxazoles and phenons as alpha2-antagonists | |
| NO20000114D0 (no) | 2,4,4-trisubstituerte-1,3-diokolan-antifungale midler | |
| DK1104419T3 (da) | N-substituerede azabicyloheptan-derivater, deres fremstilling og anvendelse |